Clinical Trials in Detroit

Showing 11381-11400 of 16,931 trials

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)

NCT03377426

The purpose of the study is to evaluate whether LYS228 can be developed for the treatment of complicated urinary tract infections

Complicated Urinary Tract Infections

Novartis PharmaceuticalsStarted Oct 2018

Detroit, Michigan, United States • Newark, New Jersey, United States • Seattle, Washington, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

NCT01147640

A Phase 2, multicenter, prospective, randomized, double-blind study of CXA-101/ tazobactam (1000/500 mg q8h) and metronidazole (500 mg q8h) IV infusion vs. meropenem IV infusion (1000 mg q8h) and a matching saline placebo (q8h) in the treatment of cIAI in adult subjects. Dose adjustments for subjects with mild renal impairment are not necessary and subjects with more severe degrees of renal failure are excluded.

Complicated Intra-abdominal Infection

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)122 participantsStarted Jun 2010

Orange, California, United States • Torrance, California, United States • Aurora, Colorado, United States +30 more locations

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)

Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

Find Trials by Condition in Detroit

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

A Study in Subjects With Moderate Atopic Dermatitis

Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)

BKM120 for Patients With PI3K-activated Tumors

Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Vidaza to Restore Hormone Thx Prostate

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis